Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HIV drug resistance' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 35 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Masquelier, B; Neau, D; Chene, G; Larbere, J; Birac, V; Ragnaud, JM; Fleury, HJA
      Mechanism of virologic failure after substitution of a protease inhibitor by nevirapine in patients with suppressed plasma HIV-1 RNA

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    2. Kyriakides, TC; Heimer, RR
      Development and application of a genotypic AZT resistance assay - Quantitative assessment of the resistance profile of clinical samples and the relative predictive ability of a resistance index

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    3. Roberts, DE; Ribeiro, RM
      Comparison of different treatment regimens for the emergence of new resistance under therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    4. Weidle, PJ; Kityo, CM; Mugyenyi, P; Downing, R; Kebba, A; Pieniazek, D; Respess, R; Hertogs, K; De Vroey, V; Dehertogh, P; Bloor, S; Larder, B; Lackritz, E
      Resistance to antiretroviral therapy among patients in Uganda

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    5. Adje, C; Cheingsong, R; Roels, TH; Maurice, C; Djomand, G; Verbiest, W; Hertogs, K; Larder, B; Monga, B; Peeters, M; Eholie, S; Bissagene, E; Coulibaly, M; Respess, R; Wiktor, SZ; Chorba, T; Nkengasong, JN
      High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Cote d'Ivoire

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    6. Haubrich, R; Demeter, L
      Clinical utility of resistance testing: Retrospective and prospective datasupporting use and current recommendations

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    7. Garcia-Lerma, JG; Heneine, W
      Resistance of human immunodeficiency virus type 1 to reverse transcriptaseand protease inhibitors: genotypic and phenotypic testing

      JOURNAL OF CLINICAL VIROLOGY
    8. Plettenberg, A; Albrecht, D; Lorenzen, T; Paech, V; Petersen, H; Fenner, T; Meyer, T; Arndt, R; Hertogs, K; Pauwels, R; Weitzel, T; Stoehr, A
      Resistance analyses in HIV infected patients with a history of multiple antiretroviral treatment regimens

      SEXUALLY TRANSMITTED INFECTIONS
    9. Jones, S; Klotman, ME
      Impact of genotypic resistance testing on physician selection of antiretroviral therapy

      JOURNAL OF HUMAN VIROLOGY
    10. Sitnitskaya, Y; Rochford, G; Rigaud, M; Essajee, S; Pollack, H; Krasinski, K; Borkowsky, W
      Prevalence of the T215Y mutation in human immunodeficiency virus type 1-infected pregnant women in a New York cohort, 1995-1999

      CLINICAL INFECTIOUS DISEASES
    11. Erice, A; Li, WY; Balfour, HH; Boies, LR; Melroe, H; Henry, K
      Analysis of HIV-1 reverse transcriptase and protease sequences in paired plasma and lymphoid tissue specimens from HIV-1 infected individuals

      AIDS
    12. Liegler, TJ; Hayden, MS; Lee, KH; Hoh, R; Deeks, SG; Grant, RM
      Protease inhibitor-resistant HIV-1 from patients with preserved CD4 cell counts is cytopathic in activated CD4 T lymphocytes

      AIDS
    13. Frater, AJ; Beardall, A; Ariyoshi, K; Churchill, D; Galpin, S; Clarke, JR; Weber, JN; McClure, MO
      Impact of baseline polymorphisms in RT and protease on outcome of highly active antiretroviral therapy in HIV-1-infected African patients

      AIDS
    14. Jones, K; Bray, PG; Khoo, SH; Davey, RA; Meaden, ER; Ward, SA; Back, DJ
      P-glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: potential for accelerated viral drug resistance?

      AIDS
    15. Montaner, JSG; Harrigan, PR; Jahnke, N; Raboud, J; Castillo, E; Hogg, RS; Yip, B; Harris, M; Montessori, V; O'Shaughnessy, MV
      Multiple drug rescue therapy for HIV-infected individuals with prior virologic failure to multiple regimens

      AIDS
    16. Deeks, SG; Martin, JN
      Reassessing the goal of antiretroviral therapy in the heavily pre-treated HIV-infected patient

      AIDS
    17. Jorgensen, LB; Katzenstein, TL; Gerstoft, J; Mathiesen, LR; Pedersen, C; Nielsen, C
      Genotypic and phenotypic nevirapine resistance correlates with virologicalfailure during salvage therapy including abacavir and nevirapine

      ANTIVIRAL THERAPY
    18. Richard, N; Salomon, H; Oliveira, M; Rando, R; Mansour, T; Gu, ZX; Wainberg, MA
      Selection of resistance-conferring mutations in HIV-1 by the nucleoside reverse transcriptase inhibitors (+/-)dOTC and (+/-)dOTFC

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    19. Brenner, B; Wainberg, MA; Salomon, H; Rouleau, D; Dascal, A; Spira, B; Sekaly, RP; Conway, B; Routy, JP
      Resistance to antiretroviral drugs in patients with primary HIV-1 infection

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    20. Baxter, JD; Mayers, DL; Wentworth, DN; Neaton, JD; Hoover, ML; Winters, MA; Mannheimer, SB; Thompson, MA; Abrams, DI; Brizz, BJ; Ioannidis, JPA; Merigan, TC
      A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy

      AIDS
    21. Maguire, M; Gartland, M; Moore, S; Hill, A; Tisdale, M; Harrigan, R; Kleim, JP
      Absence of zidovudine resistance in antiretroviral-naive patients following zidovudine/lamivudine/protease inhibitor combination therapy: virologicalevaluation of the AVANTI 2 and AVANTI 3 studies

      AIDS
    22. Puig, T; Perez-Olmeda, M; Rubio, A; Ruiz, L; Briones, C; Franco, JM; Gomez-Cano, M; Stuyver, L; Zamora, L; Alvarez, C; Leal, M; Clotet, B; Soriano, V
      Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain

      AIDS
    23. Ruiz, L; Martinez-Picado, J; Romeu, J; Paredes, R; Zayat, MK; Marfil, S; Negredo, E; Sirera, G; Tural, C; Clotet, B
      Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression

      AIDS
    24. Salomon, H; Wainberg, MA; Brenner, B; Quan, YD; Rouleau, D; Cote, P; LeBlanc, R; Lefebvre, E; Spira, B; Tsoukas, C; Sekaly, RP; Conway, B; Mayers, D; Routy, JP
      Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use

      AIDS
    25. Parkin, NT; Deeks, SG; Wrin, MT; Yap, J; Grant, RM; Lee, KH; Heeren, D; Hellmann, NS; Petropoulos, CJ
      Loss of antiretroviral drug susceptibility at low viral load during early virological failure in treatment-experienced patients

      AIDS
    26. Izopet, J; Massip, P; Souyris, C; Sandres, K; Puissant, B; Obadia, M; Pasquier, C; Bonnet, E; Marchou, B; Puel, J
      Shift in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimen

      AIDS
    27. Cunningham, PH; Smith, DG; Satchell, C; Cooper, DA; Brew, B
      Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid

      AIDS
    28. Jackson, JB; Becker-Pergola, G; Guay, LA; Musoke, P; Mracna, M; Fowler, MG; Mofenson, LM; Mirochnick, M; Mmiro, F; Eshleman, SH
      Identification of the K103N resistance mutation in Ugandan women receivingnevirapine to prevent HIV-1 vertical transmission

      AIDS
    29. Precious, HM; Gunthard, HF; Wong, JK; D'Aquila, RT; Johnson, VA; Kuritzkes, DR; Richman, DD; Brown, AJL
      Multiple sites in HIV-1 reverse transcriptase associated with virological response to combination therapy

      AIDS
    30. Martinez-Picado, J; Savara, AV; Shi, L; Sutton, L; D'Aquila, RT
      Fitness of human immunodeficiency virus type 1 protease inhibitor-selectedsingle mutants

      VIROLOGY
    31. Samri, A; Haas, G; Duntze, J; Bouley, JM; Calvez, V; Katlama, C; Autran, B
      Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cells

      JOURNAL OF VIROLOGY
    32. Devereux, HL; Youle, M; Johnson, MA; Loveday, C
      Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy

      AIDS
    33. Race, E; Dam, E; Obry, V; Paulous, S; Clavel, F
      Analysis of HIV cross-resistance to protease inhibitors using a rapid single-cycle recombinant virus assay for patients failing on combination therapies

      AIDS
    34. Birk, M; Sonnerborg, A
      Variations in HIV-1 pol gene associated with reduced sensitivity to antiretroviral drugs in treatment-naive patients

      AIDS
    35. SCHMIT JC; RUIZ L; STUYVER L; VANLAETHEM K; VANDERLINDEN I; PUIG T; ROSSAU R; DESMYTER J; DECLERCQ E; CLOTET B; VANDAMME AM
      COMPARISON OF THE LIPA HIV-1 RT TEST, SELECTIVE PCR AND DIRECT SOLID-PHASE SEQUENCING FOR THE DETECTION OF HIV-1 DRUG-RESISTANCE MUTATIONS

      Journal of virological methods


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 01:14:06